FDA panel favors Glaxo, Ligand blood drug
Friday, May 30, 2008 - 13:28
in Health & Medicine
(AP) -- Advisers to the Food and Drug Administration said Friday a blood-clotting drug from GlaxoSmithKline and Ligand Pharmaceuticals is effective for short-term use, despite reservations by FDA scientists.